Borg; Christophe
Patent Applications and Registrations
Patent applications and USPTO patent grants for Borg; Christophe.The latest application filed is for "truncated cd20 protein, deltacd20".
- Borg; Christophe - Pouilley les Vignes FR
- Borg; Christophe - Pouillet les Vignes N/A FR
| Patent | Date |
|---|---|
| Truncated CD20 protein, deltaCD20 Grant 9,388,468 - Ferrand , et al. July 12, 2 | 2016-07-12 |
| Truncated Cd20 Protein, Deltacd20 App 20140316125 - Ferrand; Christophe ; et al. | 2014-10-23 |
| Truncated CD20 protein, deltaCD20 Grant 8,759,503 - Ferrand , et al. June 24, 2 | 2014-06-24 |
| Induction of p53 expression by neutralization of neuropilin-2 for the treatment of cancers Grant 8,722,043 - Borg , et al. May 13, 2 | 2014-05-13 |
| Truncated Cd20 Protein, Deltacd20 App 20120129167 - Ferrand; Christophe ; et al. | 2012-05-24 |
| Induction of p53 expression by neutralization of neuropilin-2 for the treatment of cancers App 20120027779 - Borg; Christophe ; et al. | 2012-02-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 